Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-α therapy

1. Gonzalez-Gay, M.A.
2. Vazquez-Rodriguez, T.R.
3. Garcia-Unzueta, M.T.
4. Berja, A.
5. Miranda-Filloy, J.A.
6. De Matias, J.M.
7. Gonzalez-Juanatey, C.
8. Llorca, J.